Search Results 421-430 of 18160 for peptide therapy

1. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy

   ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...

2. Keratosis pilaris - Diagnosis and treatment - Mayo Clinic

   Treatment · Creams to remove dead skin cells. Creams containing alpha hydroxy acid, lactic acid, salicylic acid or urea help loosen and remove dead skin cells.

3. Antisocial personality disorder - Diagnosis and treatment - Mayo Clinic

   Therapy may include, for example, anger and violence management, treatment for problems with alcohol or drugs, and treatment for other mental health conditions.

4. A Study to Evaluate Nutrition Therapy in Improving Immune System in Bladder Cancer Patients - Mayo Clinic

   The purpose of this study is to evaluate how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by ...

5. Inhibiting HDAC6 and HDAC1 upregulates RhoB with divergent downstream targets, BIM

   HDAC inhibitors combined with paclitaxel may be an effective combinatorial therapy. ... vorinostat (SAHA) and the cyclic peptide ... * Romidepsin is a class I ...

6. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

   The purpose of this trilal is to study a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, ...

7. Hyperammonemia in Patients undergoing Roux-en-Y Gastric Bypass Surgery - Mayo Clinic

   By condition, treatment or drug name. Search tips. Hyperammonemia in ... The purpose of this study is to determine plasma levels of Peptide YY (PYY) ...

8. FDA approves earlier use of lutetium Lu 177 vipivotide tetraxetan for patients with PSMA-positive metastatic castration-resistant prostate cancer - Mayo Clinic

   This new indication is for patients with PSMA-positive mCRPC who have undergone ARPI therapy and are considered appropriate for delayed chemotherapy treatment.

9. Clinical trials - Oncology (Medical)

   ... therapy with daratumumab, lenalidomide and ... peptide receptor positive, estrogen receptor ... therapy in combination with a CDK4/6 inhibitor. In ...

10. Cancer Treatment Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and effectiveness of Avutometinib combined with adagrasib in patients with G12C Non-Small Cell Lung Cancer ( ...